Lipid nanoparticles: The underrated invention behind the vaccine revolution

CC0 image by torstensimon from Pixabay

Nada Salem, Chemistry editor The race to develop vaccines for COVID-19 marks the beginning of a new chapter in medicine: one where we have solutions for previously incurable diseases, more precise therapies, and phenomenally faster drug development. New frontiers in ribonucleic acid (RNA) medicine play a prominent role in this development. Ribonucleic acid is a short […]

Continue reading


Why are some Canadians hesitant about COVID-19 vaccines?

CC0 Whitesession via Pixabay

Michael Ralph Limmena, Health, Medicine and Veterinary Sciences editor   In the wake of the Canadian government’s approval of the Pfizer-BioNTech and Moderna COVID-19 vaccines in December 2020, many Canadians are eager to get vaccinated. However, some people remain hesitant. According to an IPSOS survey of 1,001 Canadians in November 2020, 28 per cent would […]

Continue reading


Adapting to change: The challenge of HIV vaccine development

by Emerson Gaglardi, New Science Communicator In 2016, 36.7 million people around the world were living with HIV (human immunodeficiency virus) infections. To put this in perspective, that is about the same as the current population of Canada. Without treatment, HIV dramatically reduces the number of infection-fighting white blood cells over a period of about […]

Continue reading